Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily versus alternate-day oral iron for iron deficiency anemia
IRCT20210730052015N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Iron in iron deficiency anemia (IDA) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Hemoglobin, Clinical signs and 3 more. Started Sep 2021; status: completed.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on IRCT20210730052015N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210730052015N1.